Modern diabetes devices adding to doctors’ workload: consensus statement
Diabetes stakeholders say there are gaps in both doctor remuneration and equity of patient access to new technologies
Doctors treating patients with type 1 diabetes are interpreting complex data generated by modern glucose monitoring devices without specific remuneration, say the authors of a consensus statement on new technologies.
While bringing benefits to many patients, technologies such as insulin pumps and continuous glucose monitoring (CGM) require ongoing detailed management discussions between doctors and patients, the leading endocrinologists say.
